The article There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance originally appeared on Fool.com. Get a brief on the top business stories of the week, plus CEO interviews ...

GlaxoSmithKline's Nucala met its primary endpoint ... we've positioned ourselves for success. And we share that positioning and all the analysis behind it with our members. Analyst’s Disclosure ...

Read our privacy notice. GlaxoSmithKline's global head of yax, Melissa Geiger, shares the secrets to her success, including staying one step ahead of a fast-moving industry and switching off with ...

GlaxoSmithKline PLC is a pharmaceutical giant ... the GSK and Novartis Consumer businesses’ joint venture with great success. The EMpower 50 Advocates Role Models 2022 named Diana Conrad as ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

GlaxoSmithKline and Theravance have been marching right along. All four of their next-generation long-lasting treatments were approved by the FDA, offering hope that a successful product launch ...